Tackling Cancer Care in the Face of Climate Change
Leticia Nogueira, PhD, MPH, discusses how healthcare professionals and patients can come together facing the threats of climate change on cancer care.
Climate change presents several hazards to patients with cancer, including disruptions in access to care and higher risk of infection. In an interview with Targeted OncologyTM, Leticia Nogueira, PhD, MPH, scientific director of health services research in the Surveillance & Health Equity Science department at the American Cancer Society, discusses how patients and healthcare providers can manage cancer care in the face of these threats.
Transcription:
Efficacy of Cilta-Cel Is Maintained in Early Relapsed Multiple Myeloma
September 20th 2024During a Case-Based Roundtable® event, Samer A. Al'Hadidi, MD, MS, discussed the CARTITUDE-4 trial of cilta-cel in patients with relapsed/refractory multiple myeloma in the first article of a 2-part series.
Read More
FDA Approves Isatuximab Plus VRd in Transplant-Ineligible Multiple Myeloma
September 20th 2024The approval is supported by data from the phase 3 IMROZ study which demonstrated superior progression-free survival with isatuximab plus VRd vs VRd alone in patients with newly diagnosed, transplant-ineligible multiple myeloma.
Read More
